Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroya Hayashi

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Respiratory Investigation|March 8, 2025
The clinical impact of acute vasoreactivity testing in patients with severe pulmonary hypertension associated with lung disease: A retrospective exploratory analysisRyo Takano, Shinya Fujisaki, Hiroyuki Endo, et al.
Journal of the American Heart Association|July 26, 2024
Prevalence and Clinical Characteristics of Heterozygous <i>RNF213 p.Arg4810Lys</i> Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary HypertensionTakatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi, et al.
Pulmonary Circulation|February 23, 2026
Pulmonary Venous Vasculopathy in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension With Reduced Diffusion Capacity for Carbon MonoxideShinya Fujisaki, Ryotaro Asano, Hiroyuki Endo, et al.
Frontiers in Cardiovascular Medicine|November 29, 2023
Quantification of pulmonary perfusion using LSIM-CT correlates with pulmonary hemodynamics in patients with CTEPDTomohiro Yamaguchi, Shoichi Ehara, Hisako Yoshida, et al.
Pulmonary Circulation|July 4, 2024
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertensionTakatoyo Kiko, Ryotaro Asano, Hiroyuki Endo, et al.
Circulation Reports|April 11, 2025
Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension - Protocol for the PHiNO StudyJin Ueda, Akihiro Tsuji, Tatsuo Aoki, et al.
Cardiovascular Intervention and Therapeutics|August 1, 2025
Long-term outcome of manual aspiration thrombectomy for acute proximal deep vein thrombosisAkihiro Tsuji, Hiroya Hayashi, Ryo Takano, et al.
Cardiovascular Diagnosis and Therapy|January 6, 2023
Cardiovascular and bleeding risks of inactive cancer in patients with acute myocardial infarction who received primary percutaneous coronary intervention using drug-eluting stent and dual/triple antithrombotic therapyHiroya Hayashi, Yu Kataoka, Kota Murai, et al.
Journal of the American Heart Association|April 16, 2025
Balloon Pulmonary Angioplasty in Heterozygous <i>RNF213</i> p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary HypertensionTakatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi, et al.
Open Heart|September 5, 2025
Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertensionRyo Takano, Aoki Tatsuo, Shinya Fujisaki, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Respiratory Investigation|March 8, 2025
The clinical impact of acute vasoreactivity testing in patients with severe pulmonary hypertension associated with lung disease: A retrospective exploratory analysisRyo Takano, Shinya Fujisaki, Hiroyuki Endo, et al.
Journal of the American Heart Association|July 26, 2024
Prevalence and Clinical Characteristics of Heterozygous <i>RNF213 p.Arg4810Lys</i> Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary HypertensionTakatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi, et al.
Pulmonary Circulation|February 23, 2026
Pulmonary Venous Vasculopathy in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension With Reduced Diffusion Capacity for Carbon MonoxideShinya Fujisaki, Ryotaro Asano, Hiroyuki Endo, et al.
Frontiers in Cardiovascular Medicine|November 29, 2023
Quantification of pulmonary perfusion using LSIM-CT correlates with pulmonary hemodynamics in patients with CTEPDTomohiro Yamaguchi, Shoichi Ehara, Hisako Yoshida, et al.
Pulmonary Circulation|July 4, 2024
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertensionTakatoyo Kiko, Ryotaro Asano, Hiroyuki Endo, et al.
Circulation Reports|April 11, 2025
Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension - Protocol for the PHiNO StudyJin Ueda, Akihiro Tsuji, Tatsuo Aoki, et al.
Cardiovascular Intervention and Therapeutics|August 1, 2025
Long-term outcome of manual aspiration thrombectomy for acute proximal deep vein thrombosisAkihiro Tsuji, Hiroya Hayashi, Ryo Takano, et al.
Cardiovascular Diagnosis and Therapy|January 6, 2023
Cardiovascular and bleeding risks of inactive cancer in patients with acute myocardial infarction who received primary percutaneous coronary intervention using drug-eluting stent and dual/triple antithrombotic therapyHiroya Hayashi, Yu Kataoka, Kota Murai, et al.
Journal of the American Heart Association|April 16, 2025
Balloon Pulmonary Angioplasty in Heterozygous <i>RNF213</i> p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary HypertensionTakatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi, et al.
Open Heart|September 5, 2025
Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertensionRyo Takano, Aoki Tatsuo, Shinya Fujisaki, et al.
Pageof 5